Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2012 01:30 ET | Source: NICOX SA

NicOx Board decides not to exercise its option to acquire the remaining shares of Altacor

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE NicOx Board decides not to exercise its...
May 31, 2012 18:07 ET | Source: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Strengthens Global Aganocide(R) Patent Estate With Seven New Patents

EMERYVILLE, Calif., May 31, 2012 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE AMEX:NBY), a clinical-stage biotechnology company developing first-in-class "non-antibiotic anti-infective"...
May 31, 2012 08:00 ET | Source: BIO-key International, Inc

BIO-key(R) International, Inc. & Medflow Provide Innovative Authentication Solution for Ophthalmology Practices

WALL, N.J., May 31, 2012 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology,...
May 30, 2012 14:30 ET | Source: Memorial Hermann

Memorial Hermann-Texas Medical Center Establishes The Texas Trauma Institute

HOUSTON, May 30, 2012 (GLOBE NEWSWIRE) -- As nationally recognized leaders in trauma care with one of the country's busiest Level 1 trauma centers, the Memorial Hermann – Texas Medical Center...
May 24, 2012 05:12 ET | Source: CorrectVision Laser Institute

Cataract Surgeons in Fort Lauderdale Say Aging Eyes May Impact Body's Internal Clock

FORT LAUDERDALE, FL--(Marketwire - May 24, 2012) - Several recent studies in ophthalmology and biological rhythms may have linked aging eyes with a number of health concerns ranging from memory...
May 18, 2012 06:05 ET | Source: NICOX SA

NicOx's Ordinary Shareholder Meeting on June 6, 2012

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ALERT NicOx's Ordinary...
May 17, 2012 07:00 ET | Source: NovaBay Pharmaceuticals, Inc.

NovaBay Enrolls First Patients in Global BAYnovation(TM) Phase 2b Study for Adenoviral Conjunctivitis

Study Design Includes FDA Recommendations Following Successful End-of-Phase 2a Meeting EMERYVILLE, Calif., May 17, 2012 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE AMEX:NBY),...
May 15, 2012 14:44 ET | Source: NIDEK, Inc.

Photo Release -- NIDEK and MARCO Announce FDA 510(K) Clearance for the AFC-330 - Automated Fundus Camera

FREMONT, Calif. and JACKSONVILLE, Fla., May 15, 2012 (GLOBE NEWSWIRE) -- NIDEK, a global leader in the design, manufacturing, and distribution of ophthalmic equipment, announces the FDA 510(k)...
May 10, 2012 01:30 ET | Source: NICOX SA

NicOx reports first quarter 2012 financial results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE NicOx reports first quarter 2012...
May 10, 2012 01:15 ET | Source: Novartis Pharma AG

New data among 200 Lucentis® abstracts at ARVO show low number of injections with Novartis drug required to achieve and maintain vision gains over 3 years in AMD and DME patients

Data from key studies highlight the value of individualized therapy and reinforce Lucentis (ranibizumab) well-characterized long-term efficacy and safety profile RESTORE extension study in DME...